Dr. Justin Graham, Chief Medical Officer, GYANT
The rapid development of a COVID-19 vaccine is a monumental achievement, but it does nothing to address our extremely fragmented healthcare system. In 2021, policymakers must create and extend incentives to providers to work together to keep patients healthy rather than maximize profit. The pandemic has devastated the traditional fee-for-service budgets of many healthcare systems, and it isn't clear they will ever be able to catch up without
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Gladskin’s President Skyler Stein Talks Endolysin Technology – Q/A
We recently spoke with Skyler Stein, President of Dutch biotechnology company Gladskin to learn more about its global endolysin technology that uses its science to improve inflammatory skin conditions by rebalancing the skin microbiome. Gladskin's parent company, Micreos, raised about $36.7M in funding last year for its endolysin technology that is poised to replace many antibiotics and overcome some of the challenges of antimicrobial resistance.
HITC: Skyler, can you speak more
about
Read More
Vaccine Safety Expert Shares 5 COVID-19 Vaccine Facts to Protect 2021
Now more than ever, public confidence is key. It's our job as medical professionals, the FDA's job, and public figures' job to convince the population to vaccinate by presenting the real results of studies.
The current vaccine hesitancy, which might result in a large proportion of people refusing vaccination, will leave us with an ongoing global crisis, even with the best vaccines ever made. A vaccine only works if it is actually administered.
Five Vaccine Facts to Protect
Read More
Verily Nabs $700M to Expand Baseline, Verily Health Platforms
What You Should Know:
- Verily, a subsidiary of
Alphabet focused on life sciences and healthcare announced it has raised $700M
from current investors, including Alphabet, Silver Lake, Temasek, Ontario Teachers’ Pension Plan and others.
- The company plans to use the capital to support rapid
expansion of some of Verily’s leading commercial businesses including Baseline, an end-to-end ecosystem
designed to make clinical research more efficient; and Verily Health Platforms,
which supports
Read More
How Hackers Are Targeting COVID-19 Vaccine Distribution Chains – Q/A
With the US and other major countries poised to begin national
distribution of multiple FDA-approved COVID-19 vaccines, the cybersecurity threats
to secure COVID19
vaccine distribution is imminent. Earlier this month, IBM released a report on malicious cyber actors targeting
the COVID-19 cold chain—an integral part of delivering and storing a vaccine at
safe temperatures.
Impersonating a biomedical company, cyber actors are sending phishing and spear-phishing emails to executives and global
Read More
M&A: Cerner to Acquire Health Division of Kantar for $375M in Cash
What You Should Know:
- Cerner announces it will acquire Kantar Health, a leading data, analytics, and real-world evidence and commercial research consultancy serving the life science and health care industry.
- This acquisition is expected to allow Cerner’s Learning
Health Network client consortium and health systems with more opportunities to
directly engage with life sciences for funded research studies. The acquisition
is expected to close during the first half of
Read More
FDA Authorizes First Fully Over the Counter COVID-19 Home Test
What You Should Know:
- FDA grants Emergency Use Authorization for Ellume
COVID-19 Home Test for non-prescription home use in symptomatic and
asymptomatic individuals
- The first fully over-the-counter COVID-19 Home Test
demonstrated 96% accuracy in a multi-site US clinical study of both adults and
children 2 years and above
- Ellume is ramping up manufacture, with production on
track for over 100,000 tests per day in January 2021
Ellume, a
digital diagnostics announced its rapid,
Read More
Abbott Receives CE Mark for its COVID-19 IgG Quantitative Antibody Blood Test
What You Should Know:
- Abbott Receives CE Mark for its COVID-19 IgG Quantitative Antibody Blood Test that specifically detects levels of IgG antibodies that attach to the virus’ spike protein, which can be helpful to evaluate a person's immune response to vaccines.
- Abbott plans to submit its test for the U.S. Food and Drug Administration (FDA) emergency use authorization soon.
Abbott, today
announced it received CE Mark for its new quantitative SARS-CoV-2 IgG
(Immunoglobulin G)
Read More
Backed by Khosla Ventures, Rubedo Life Sciences Secures $12M for Drug Discovery Platform
What You Should Know:
- Biopharma startup Rubedo Life Sciences raises $12M to develop a broad portfolio of innovative therapies engineered to target cells for chronic age-related diseases.
- Rubedo’s proprietary ALEMBIC™ drug discovery platform, has generated a novel pipeline of therapeutic candidates that selectively target senescent cells, pro-inflammatory and pro-fibrotic cell populations that result from a variety of cellular stress and damage.
Rubedo Life Sciences, a
Read More
UCB Taps Medisafe to Develop Branded Digital Drug Companions for Antiepileptic Medications
What You Should Know:
- UCB has selected Medisafe to develop branded digital
drug companions for antiepileptic medications, marking the company’s official
entry into the digital therapeutics space.
- The initial collaboration will primarily be focused on their antiepileptic medications, but they are exploring its use for additional brands.
Medisafe,
a leading digital
therapeutics company specializing in digital companions, has been selected
by UCB to develop branded digital
Read More
